March 13, 2020 / 12:12 PM / 21 days ago

BRIEF-La Jolla Pharmaceutical To Provide GIAPREZA In Italy For Use In Patients With Septic Shock Associated With COVID-19

March 13 (Reuters) - La Jolla Pharmaceutical Co:

* LA JOLLA PHARMACEUTICAL CO - PROVIDING GIAPREZA IN ITALY FOR COMPASSIONATE USE IN PATIENTS WITH SEPTIC SHOCK ASSOCIATED WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below